Get the Stockscreener App
13.79
1.99%
-0.28
After Hours:
13.79
Prothena Corporation Plc Stock (PRTA) Latest News
Prothena (NASDAQ:PRTA) Price Target Raised to $62.00 - Defense World
Prothena (NASDAQ:PRTA) Given New $62.00 Price Target at Oppenheimer - MarketBeat
32,129 Shares in Prothena Co. plc (NASDAQ:PRTA) Purchased by Focused Wealth Management Inc - MarketBeat
Form S-8Securities to be offered to employees in employee benefit plans - br.ADVFN.com
Learn to Evaluate (PRTA) using the Charts - Stock Traders Daily
Deep Dive Into Prothena Corp Stock: Analyst Perspectives (5 Ratings) - Benzinga
Metric Analysis: Prothena Corporation plc (PRTA)’s Key Ratios in the Limelight - The Dwinnex
SG Americas Securities LLC Increases Stock Position in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Q2 Earnings Forecast for Prothena Issued By Zacks Research - MarketBeat
Prothena (NASDAQ:PRTA) Stock Price Down 4.8%Here's What Happened - MarketBeat
SG Americas Securities LLC Increases Holdings in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Equities Analysts Offer Predictions for Prothena Q2 Earnings - Defense World
Brokerages Set Prothena Co. plc (NASDAQ:PRTA) Price Target at $46.50 - Defense World
Duncan Williams Asset Management LLC Has $958,000 Position in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Prothena Co. plc (NASDAQ:PRTA) Receives $46.50 Consensus PT from Brokerages - MarketBeat
Prothena (NASDAQ:PRTA) Trading 6.7% HigherHere's Why - MarketBeat
Insufficient Growth At Prothena Corporation plc (NASDAQ:PRTA) Hampers Share Price - Simply Wall St
Cantor Fitzgerald Predicts Prothena FY2025 Earnings - Defense World
Cantor Fitzgerald Forecasts Prothena FY2025 Earnings - MarketBeat
JPMorgan Chase & Co. Lowers Holdings in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
JPMorgan Chase & Co. Has $3.35 Million Stock Position in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Hennion & Walsh Asset Management Inc. Takes $724,000 Position in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Prothena (NASDAQ:PRTA) Shares Up 6.8%Time to Buy? - MarketBeat
Trading (PRTA) With Integrated Risk Controls - Stock Traders Daily
AL Amyloidosis Pipeline Analysis 2024: FDA Approvals, Emerging - openPR
Barclays PLC Grows Stock Holdings in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Prothena Co. plc (NASDAQ:PRTA) Shares Purchased by Barclays PLC - Defense World
Prothena (NASDAQ:PRTA) Stock Price Down 9%Here's What Happened - MarketBeat
Prothena (NASDAQ:PRTA) Trading Up 6.5%What's Next? - MarketBeat
Prothena Co. plc (NASDAQ:PRTA) Receives $52.29 Average Price Target from Analysts - Defense World
Prothena Corporation plc (NASDAQ: PRTA) Down -6.92%: Here’s What Analysts’ Predictions Are Now. - Stocks Register
Brokerages Set Prothena Co. plc (NASDAQ:PRTA) Price Target at $52.29 - MarketBeat
Prothena (NASDAQ:PRTA) Trading Down 2.6%Time to Sell? - MarketBeat
Prothena Corporation PLC (NASDAQ:PRTA) Director Oleg Nodelman Resigns - Defense World
Prothena Director Oleg Nodelman Steps Down After 5-Year Tenure, Ahead of Major 2025 Clinical Milestones - StockTitan
Prothena Co. plc (NASDAQ:PRTA) Shares Sold by Geode Capital Management LLC - Defense World
Prothena Announces Board of Directors Update - Business Wire
Prothena Co. plc (NASDAQ:PRTA) Shares Bought by Barclays PLC - Defense World
Barclays PLC Buys 49,916 Shares of Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
How the (PRTA) price action is used to our Advantage - Stock Traders Daily
We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate - Yahoo Finance
Prothena Co. plc (NASDAQ:PRTA) Position Trimmed by State Street Corp - Defense World
Prothena Co. plc (NASDAQ:PRTA) Holdings Decreased by State Street Corp - MarketBeat
Prothena Surges After Parkinson's Drug Misses Primary Endpoint - Seeking Alpha
Prothena (NASDAQ:PRTA) Earns Buy Rating from HC Wainwright - MarketBeat
Prothena (NASDAQ:PRTA) Coverage Initiated at Chardan Capital - MarketBeat
Demystifying Prothena Corp: Insights From 6 Analyst Reviews - Benzinga
Even after rising 16% this past week, Prothena (NASDAQ:PRTA) shareholders are still down 67% over the past three years - Simply Wall St
Prothena Corp (NASDAQ:PRTA) Stock Quotes, Forecast and News Summary - Benzinga
Prothena Shares Surge 43% Despite Setback in Parkinson's Drug Trial, Investors Eye Future Potential - mediahousepress
Prothena stock soars despite study miss By Investing.com - Investing.com Canada
Prothena stock soars despite study miss - Investing.com
Prothena (NASDAQ:PRTA) Price Target Cut to $22.00 by Analysts at Bank of America - MarketBeat
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):